R
Ryvu Therapeutics SA
WSE:RVU
Ryvu Therapeutics SA
WSE:RVU
Price:
23.4
PLN
2.18%
Market Closed
Market Cap:
zł541m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
PL |
|
Irisity AB (publ)
F:69M
|
SE |
|
L
|
Lexington Biosciences Holdings Corp
OTC:LXGTF
|
CA |
|
I
|
International Business Machines Corp
SGO:IBM
|
US |
|
Resimac Group Ltd
ASX:RMC
|
AU |
|
H
|
Hanryu Holdings Inc
NASDAQ:HRYU
|
KR |
|
A
|
Addi Industries Ltd
BSE:507852
|
IN |
|
Spring Real Estate Investment Trust
HKEX:1426
|
HK |
|
N
|
Nuscale Power Corp
NYSE:SMR
|
US |
|
M
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
US |
|
Isetan Mitsukoshi Holdings Ltd
TSE:3099
|
JP |
|
F
|
FGI Industries Ltd
NASDAQ:FGI
|
US |
|
V
|
Vietnam National Reinsurance Corp
VN:VNR
|
VN |
|
Can2 Termik AS
IST:CANTE.E
|
TR |
|
S
|
Sun Yad Construction Co Ltd
TWSE:1316
|
TW |
|
A
|
Amazon.com Inc
XHAM:AMZ
|
US |
|
B
|
Bengal Tea & Fabrics Ltd
BSE:532230
|
IN |
|
Siam Cement PCL
SET:SCC
|
TH |
|
Yokogawa Electric Corp
TSE:6841
|
JP |
|
King Slide Works Co Ltd
TWSE:2059
|
TW |
|
Mandom Indonesia Tbk PT
IDX:TCID
|
ID |
|
Fomento de Construcciones y Contratas SA
MAD:FCC
|
ES |
|
A
|
Atalaya Mining PLC
LSE:ATYM
|
CY |
|
VisasQ Inc
TSE:4490
|
JP |
Multiples-Based Value
The Multiples-Based Value of one RVU stock under the Base Case scenario is hidden PLN. Compared to the current market price of 23.4 PLN, Ryvu Therapeutics SA is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RVU Multiples-Based Value
LOCKED
Multiples Across Competitors
RVU Competitors Multiples
Ryvu Therapeutics SA Competitors
Ryvu Therapeutics SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| PL |
R
|
Ryvu Therapeutics SA
WSE:RVU
|
541m PLN | 7.8 | -4.6 | -4.3 | -4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
975.8B USD | 341.7 | 4 045.6 | 1 159.2 | 2 232.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.2B USD | 4.1 | 27.5 | 19.1 | 25.6 | |
| US |
|
Danaher Corp
NYSE:DHR
|
135B USD | 5.5 | 37.4 | 19 | 27.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.2B CHF | 5.3 | 36.6 | 27.3 | 27.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
298.3B CNY | 6.6 | 15.6 | 16.2 | 16.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.2B USD | 4.6 | 25 | 18.4 | 21.7 | |
| US |
|
Waters Corp
NYSE:WAT
|
30.2B USD | 9.5 | 46.9 | 30.3 | 38.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.9B USD | 1.8 | 21.4 | 11.9 | 17.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.9B USD | 6.4 | 29.7 | 22.1 | 24.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
